SQI Diagnostics Inc. (SQIDF)

0.0149 0.0000 (0.00%) At close: 02:06PM EDT

SQI Diagnostics Inc.

36 Meteor Drive
Toronto, ON M9W 1A4
Canada

https://www.sqidiagnostics.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Andrew Morris	Advisor to the Board & CEO	397.13k	N/A	1966
Mr. Morlan Reddock C.F.A., CPA, CGA, M.B.A.	CFO & VP of Administration	146.26k	N/A	N/A
Dr. Eric Brouwer Ph.D.	Chief Scientific Officer & Advisor to the Board	255.96k	N/A	1969
Dr. Peter Lea Ph.D.	Founder	N/A	N/A	1945
Mr. Tim McGough	Chief Commercial Officer	N/A	N/A	N/A

Amounts are as of 31 December 2016, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow. The company was founded in 1999 and is headquartered in Toronto, Canada.

Corporate governance

SQI Diagnostics Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.